Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2007-07-03
2007-07-03
Priebe, Scott D. (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S269100, C435S258300, C435S476000, C435S479000
Reexamination Certificate
active
11091882
ABSTRACT:
The present invention discloses the use of a mutantLeishmaniaas a suicidal vaccine wherein the mutantLeishmaniais responsive to external signals to become porphyric and commit suicidal cytolysis. The mutant can be selected from naturalLeishmaniaspecies or constructed by genetic engineering.
REFERENCES:
patent: 2004/0092467 (2004-05-01), Chang et al.
Abels C, Fritsch C, Bolsen K, Szeimies RM, Ruzicka T, Goerz G, Goetz AE. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo. Journal of Photochemistry and Photobiology, B. Aug. 1997; 40(1):76-83.
Afonso SG, Chinarro S, Munoz JJ, de Salamanca RE, Battle AM. Photodynamic and non-photodynamic action of several porphyrins on the activity of some heme-enzymes, Journal of Enzyme Inhibitors. 1990; 3(4):303-10.
Ahmed SB, Bahloul C, Robbana C, Askri S, Dellagi K. A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due toLeishmania major. Vaccine, 2004; 22:1631-9.
Akman L, Aksu HS, Wang RQ, Ozensoy S, Ozbel Y, Alkan Z, Ozcel MA, Culha G, Ozcan K, Uzun S, Memisoglu HR, Chang KP, Multi-site DNA polymorphism analyses ofLeishmaniaisolates define their genotypes predicting clinical epidemiology of leishmaniasis in a specific region. J. Eukaryot Microbiol. 2000; 47:545-54.
Alexander J, Coombs GH, Mottram JC.Leishmania mexicanacysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J Immunol. 1998; 161:6794-801.
Anderson WL, Shechter Y, Parikh I. Quantitation of methionyl peptides in nanomole quantities by a fluorometric method. Anal Biochem. 1978; 91:481-9.
Belkaid, Y., H. Jouin and G. Milon (1996). “A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice.” J Immunol Methods 199(1): 5-25.
Belkaid Y, Kamhawi S, Modi G, Valenzuela J, Noben-Trauth N, Rowton E, Ribeiro J, Sacks DL. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome ofLeishmania majorinfection in the mouse ear dermis. J Exp Med. 1998; 188:1941-53.
Bissonnette R, Tremblay JF, Juzenas P, Boushira M, Lui H. Systemic photodynamic therapy with aminolevullinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques. Journal of Investigative Dermatology. Jul. 2002;119(1):77-83.
Burchmore RJ, Rodriguez-Contreras D, McBride K, Merkel P, Barrett MP, Modi G, Sacks D, Landfear SM. Genetic characterization of glucose transporter function inLeishmania mexicana. Proc Natl Acad Sci U S A. 2003; 100:3901-6.
Campbell K, Diao H, Ji J, Soong L. DNA immunization with the gene encoding P4 nuclease ofLeishmania amazonensisprotects mice against cutaneous Leishmaniasis. Infect Immun. 2003; 71:6270-8.
Campbell K, Popov V, Soong L. Identification and molecular characterization of a gene encoding a protectiveLeishmania amazonensisTrp-Asp (WD) protein. Infect Immun. 2004; 72:2194-202.
Castro DJ, Saxton RE, Soudant J. The concept of laser phototherapy. Otolaryngolical Clinic of North America. Dec. 1996;29(6):1011-29.
Chang KP. Human cutaneous Leishmanias in a mouse macrophage line: propagation and isolation of intracellular parasites. Science. 1980; 209:1240-42.
Chang KP. Intracellular multiplication ofLeishmania donovaniduring repeated passages in primary cultures of hamster peritoneal macrophages. J Parasitol. 1978; 64:931-3.
Chang KP, Akman L, Nielsen JS. Leishmania virulence and genetic heterogeneity. Clinical Dermatology. May-Jun. 1999;17(3):269-73.
Chang KP, Chang CS, Sassa S. Heme biosynthesis in bacterium-protozoon symbioses: enzymic defects in host hemoflagellates and complemental role of their intracellular symbiotes. Proc Natl Acad Sci U S A. 1975; 72:2979-83.
Chang.KP, Dwyer DM. Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro. Science. 1976; 193:678-80.
Chang KP, Hendricks DL. Laboratory cultivation and maintence ofLeishmania.In: Human Parasite Diseases. vol. 1, Leishmaniasis (Chang K.-P. and Bray RS, eds). 1985; Elsevier, Amsterdam. pp. 213-246.
Chang KP, Reed SG, McGwire BS, Soong L.Leishmaniamodel for microbial virulence: the relevance of parasite multiplication and pathoantigenicity. Acta Trop. 2003; 85:375-90.
Chang KP, Trager W. Nutritional significance of symbiotic bacteria in two species of hemoflagellates. Science. 1974; 183:531-2.
Chakrabarty R, Mukherjee S, Lu HG, McGwire BS, Chang KP, Basu MK. Kinetics of entry of virulent and avirulent strains ofLeishmania donovaniinto macrophages: a possible role of virulence molecules (gp63 and LPG). Journal of Parasitology. Aug. 1996;82(4):632-5.
Chen DQ, Kolli BK, Yadava N, Lu HG, Gilman-Sachs A, Peterson DA, Chang KP. Episomal expression of specific sense and antisense mRNAs inLeishmania amazonensis: modulation of gp63 level in promastigotes and their infection of macrophages in vitro. Infect Immun. 2000; 68:80-6.
Chen DQ, Lu H, Chang KP. Replacement ofLeishmaniaN-acetylglucosamine-1-phosphate transferase gene requires episomal rescue. Mol Biochem Parasitol. 1999; 100:223-7.
Chicharro C, Alvar J. Lower trypanosomatids in HIV/AIDS patients. Ann Trop Med Parasitol. 2003; 97 Suppl. 1:75-8.
Coler RN, Skeiky YA, Bernards K, Greeson K, Carter D, Cornellison CD, Modabber F, Campos-Neto A, Reed SG. Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant,Leishmania majorstress-inducible protein I, andLeishmaniaelongation initiation factor protects against leishmaniasis. Infect Immun. 2002; 70:4215-25.
Cruz A, Coburn CM, Beverly SM. Double targeted gene replacement for creating null mutants. Proc Natl Sci U S A. 1991; 88:7170-4.
Du Y, Maslov DA, Chang KP. Monophyletic origin of beta-division proteobacterial endosymbionts and their coevolution with insect trypanosomatid protozoa Blastocrithidia culicis and Crithidia spp. Proceedings of the National Academy of Science U S A. Aug. 30, 1994;91(18):8 437-41.
Edgeworth RL, San JH, Rosenzweig JA, Nguyen NL, Boyer JD, Ugen KE. Vaccine development against HIV-1: current perspectives and future directions. Immunology Res. 2002;25(1):53-74.
Etges R, Muller I. Progressive disease or protective immunity toLeishmania majorinfection: the result of a network of stimulatory and inhibitory interactions. J Mol Med. 1998; 76:372-90.
Freedman DJ, Beverly SM. Two more independent selectable markers for stable transfection ofLeishmania. Mol Biochem Parasitol. 1993; 62:37-44
Friesen SA, Hjortland GO, Madsen SJ, Hirschberg H, Engebraten O, Nesland JM, Peng Q. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (Review). International Journal of Oncology. Sep. 2002;21(3):577-82.
Gibson SL, Havens JJ, Nguyen ML, Hilf R. Delta-aminolaevulinic acid-induced photodynamic therapy inhibits photoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro. British Journal of Cancer. Jun. 1999;80(7):998-1004.
Glerum DM, Shtanko A, Tzagoloff A, Gorman N, Sinclair PR. Cloning and identification of HEM14, the yeast gene for mitochondrial protoporphyrinogen oxidase. Yeast. Nov. 1996;12(14):1421-5.
Gourley DG, Schuttelkopf AW, Leonard GA, Luba J, Hardy LW, Beverly SM, Hunter WN. Pteridine reductase correlates pterin metabolism with drug resistance intrypanosomatid parasites. National Structure Biology. Jun. 2001;8(6):521-5.
Goyard S, Beverley SM. Blasticidin resistance: a new independent marker for stable transfection ofLeishmania. Mol Biochem Parasitol. 2000; 108:249-52.
Gramiccia M, Gradoni L, Troiani M. HIV-Leishmaniaco-infections in Italy. Isoenzyme characterization ofLeishmaniacausing visceral leishmaniasis in HIV patients. Trans R Soc Trop Med Hyg. 1992; 86:161-3.
Gumy A, Louis JA, Launois P. The murine model of infection withLeishmania majorand its importance for the deciphering of mechanisms underlying differences in Th cell differentation in mice from different genetic backgrounds. Int J Parasitol. 2004; 34:433-44.
Harth Y, Hirshowitz B, Kaplan B. Modified topi
Chang Kwang-Poo
Kolli Bala Krishna
Sassa Shigeru
Everest Intellectual Property Law Group
Priebe Scott D.
Rosalind Franklin University of Medicine and Science
Yeung Tin-Chuen
LandOfFree
Suicidal mutant Leishmania vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suicidal mutant Leishmania vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suicidal mutant Leishmania vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3805750